Uppdrag | 19 May 2017

Setterwalls has advised Diamyd Medical in rights issue

Responsive image

Setterwalls has acted as legal adviser to Diamyd Medical AB (publ) in connection with rights issue.

Diamyd Medical develops vaccine to considerably improve the life quality for persons with different types of diabetes and inflammatory diseases.

Kontakt:

Marcus Nivinger, Linnea Gävbo

Verksamhetsområde:

Equity Capital Markets

  • This field is for validation purposes and should be left unchanged.

Do you want to get in touch with us?

Please fill out the form and we will contact you as soon as possible.

Relaterade nyheter

Setterwalls advises Crunchfish in connection with a rights issue

Uppdrag | 06 Nov 2024

Setterwalls advises Crunchfish in connection with a rights issue

Läs mer
Setterwalls advised Balder in connection with directed share issue of approximately SEK 1.5 billion

Uppdrag | 04 Nov 2024

Setterwalls advised Balder in connection with directed share issue of approximately SEK 1.5 billion

Läs mer
Setterwalls advised Enzymatica AB (publ) in connection with a rights issue

Uppdrag | 17 Sep 2024

Setterwalls advised Enzymatica AB (publ) in connection with a rights issue

Läs mer
Load more